Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TYZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,292
Award facts
- Contract value 100% obligated
- $12,291.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $12,291.71, was awarded on January 20, 2026, to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets (30-count units) to support federal medical procurement needs. The award was made by the Defense Logistics Agency under a firm fixed-price contract structure with no set-aside designation, indicating open and competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., one of the nation's largest pharmaceutical distributors serving federal healthcare systems.
This delivery order represents a task order issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract with the Defense Logistics Agency's Troop Support Medical division (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. XELJANZ XR is a prescription immunosuppressant medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the breadth of pharmaceutical commodities covered under this strategic contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F3TYZ?
SPE2DR26F3TYZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F3TYZ worth?
The government has obligated $12,292 on SPE2DR26F3TYZ.
Is contract SPE2DR26F3TYZ an order under another contract?
Yes. SPE2DR26F3TYZ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TYZ competed?
The extent of competition for SPE2DR26F3TYZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award